Literature DB >> 25788415

Activated k-ras, but not h-ras or N-ras, regulates brain neural stem cell proliferation in a raf/rb-dependent manner.

R Hugh F Bender1, Kevin M Haigis2, David H Gutmann1.   

Abstract

Neural stem cells (NSCs) give rise to all the major cell types in the brain, including neurons, oligodendrocytes, and astrocytes. However, the intracellular signaling pathways that govern brain NSC proliferation and differentiation have been incompletely characterized to date. Since some neurodevelopmental brain disorders (Costello syndrome and Noonan syndrome) are caused by germline activating mutations in the RAS genes, Ras small GTPases are likely critical regulators of brain NSC function. In the mammalian brain, Ras exists as three distinct molecules (H-Ras, K-Ras, and N-Ras), each with different subcellular localizations, downstream signaling effectors, and biological effects. Leveraging a novel series of conditional-activated Ras molecule-expressing genetically engineered mouse strains, we demonstrate that activated K-Ras, but not H-Ras or N-Ras, expression increases brain NSC growth in a Raf-dependent, but Mek-independent, manner. Moreover, we show that activated K-Ras regulation of brain NSC proliferation requires Raf binding and suppression of retinoblastoma (Rb) function. Collectively, these observations establish tissue-specific differences in activated Ras molecule regulation of brain cell growth that operate through a noncanonical mechanism.
© 2015 AlphaMed Press.

Entities:  

Keywords:  Cell proliferation; Neural stem cells; Raf kinases; Ras proteins; Retinoblastoma protein

Mesh:

Substances:

Year:  2015        PMID: 25788415      PMCID: PMC4889217          DOI: 10.1002/stem.1990

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  78 in total

1.  Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner.

Authors:  Da Yong Lee; Tu-Hsueh Yeh; Ryan J Emnett; Crystal R White; David H Gutmann
Journal:  Genes Dev       Date:  2010-09-28       Impact factor: 11.361

2.  The master negative regulator REST/NRSF controls adult neurogenesis by restraining the neurogenic program in quiescent stem cells.

Authors:  Zhengliang Gao; Kerstin Ure; Peiguo Ding; Mostafa Nashaat; Laura Yuan; Jing Ma; Robert E Hammer; Jenny Hsieh
Journal:  J Neurosci       Date:  2011-06-29       Impact factor: 6.167

3.  The bHLH gene hes1 as a repressor of the neuronal commitment of CNS stem cells.

Authors:  Y Nakamura; S i Sakakibara; T Miyata; M Ogawa; T Shimazaki; S Weiss; R Kageyama; H Okano
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

4.  Identification of the 14.3.3 zeta domains important for self-association and Raf binding.

Authors:  Z J Luo; X F Zhang; U Rapp; J Avruch
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

5.  Disruption of the mouse Rce1 gene results in defective Ras processing and mislocalization of Ras within cells.

Authors:  E Kim; P Ambroziak; J C Otto; B Taylor; M Ashby; K Shannon; P J Casey; S G Young
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

6.  Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.

Authors:  W G Janzarik; C P Kratz; N T Loges; H Olbrich; C Klein; T Schäfer; W Scheurlen; W Roggendorf; C Weiller; C Niemeyer; R Korinthenberg; S Pfister; H Omran
Journal:  Neuropediatrics       Date:  2007-04       Impact factor: 1.947

7.  Germline KRAS mutations cause Noonan syndrome.

Authors:  Suzanne Schubbert; Martin Zenker; Sara L Rowe; Silke Böll; Cornelia Klein; Gideon Bollag; Ineke van der Burgt; Luciana Musante; Vera Kalscheuer; Lars-Erik Wehner; Hoa Nguyen; Brian West; Kam Y J Zhang; Erik Sistermans; Anita Rauch; Charlotte M Niemeyer; Kevin Shannon; Christian P Kratz
Journal:  Nat Genet       Date:  2006-02-12       Impact factor: 38.330

8.  A comprehensive survey of Ras mutations in cancer.

Authors:  Ian A Prior; Paul D Lewis; Carla Mattos
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

9.  Raf-1 activation disrupts its binding to keratins during cell stress.

Authors:  Nam-On Ku; Haian Fu; M Bishr Omary
Journal:  J Cell Biol       Date:  2004-08-16       Impact factor: 10.539

10.  Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness.

Authors:  Natacha Bohin; Tiffany Wen; Qing Li; Victor Ng; Jeffrey Magee; Shann-Ching Chen; Kevin Shannon; Sean J Morrison
Journal:  Nature       Date:  2013-11-27       Impact factor: 49.962

View more
  11 in total

1.  Ras Variant Biology and Contributions to Human Disease.

Authors:  Ian Prior
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Oncogenic Ras Isoforms Signaling Specificity at the Membrane.

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  Cancer Res       Date:  2017-12-22       Impact factor: 12.701

Review 3.  Contextual signaling in cancer.

Authors:  Laura J Smithson; Corina Anastasaki; Ran Chen; Joseph A Toonen; Sidney B Williams; David H Gutmann
Journal:  Semin Cell Dev Biol       Date:  2016-06-03       Impact factor: 7.727

4.  Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide.

Authors:  Ralf S Schmid; Jeremy M Simon; Mark Vitucci; Robert S McNeill; Ryan E Bash; Andrea M Werneke; Lauren Huey; Kristen K White; Matthew G Ewend; Jing Wu; C Ryan Miller
Journal:  Neuro Oncol       Date:  2016-01-28       Impact factor: 12.300

5.  Systems Biomedicine of Rabies Delineates the Affected Signaling Pathways.

Authors:  Sadegh Azimzadeh Jamalkandi; Sayed-Hamidreza Mozhgani; Hamid Gholami Pourbadie; Mehdi Mirzaie; Farshid Noorbakhsh; Behrouz Vaziri; Alireza Gholami; Naser Ansari-Pour; Mohieddin Jafari
Journal:  Front Microbiol       Date:  2016-11-07       Impact factor: 5.640

6.  Quantification of spatiotemporal patterns of Ras isoform expression during development.

Authors:  Anna U Newlaczyl; Judy M Coulson; Ian A Prior
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

7.  Status of KRAS in iPSCs Impacts upon Self-Renewal and Differentiation Propensity.

Authors:  Kenji Kubara; Kazuto Yamazaki; Yasuharu Ishihara; Takuya Naruto; Huan-Ting Lin; Ken Nishimura; Manami Ohtaka; Mahito Nakanishi; Masashi Ito; Kappei Tsukahara; Tomohiro Morio; Masatoshi Takagi; Makoto Otsu
Journal:  Stem Cell Reports       Date:  2018-07-05       Impact factor: 7.765

8.  Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal.

Authors:  Tin Fan Chai; Kanjoormana Aryan Manu; Patrick J Casey; Mei Wang
Journal:  Oncogene       Date:  2020-06-19       Impact factor: 9.867

9.  Characteristics of Genetic Variations Associated With Lennox-Gastaut Syndrome in Korean Families.

Authors:  Jin Ok Yang; Min-Hyuk Choi; Ji-Yong Yoon; Jeong-Ju Lee; Sang Ook Nam; Soo Young Jun; Hyeok Hee Kwon; Sohyun Yun; Su-Jin Jeon; Iksu Byeon; Debasish Halder; Juhyun Kong; Byungwook Lee; Jeehun Lee; Joon-Won Kang; Nam-Soon Kim
Journal:  Front Genet       Date:  2021-01-20       Impact factor: 4.599

10.  Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation.

Authors:  Zixing Liu; Wenling Zhang; Joshua B Phillips; Ritu Arora; Steven McClellan; Jiangfeng Li; Jin-Hwan Kim; Robert W Sobol; Ming Tan
Journal:  Oncogene       Date:  2018-08-06       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.